Molecular medicine and Personalized Healthcare

Molecular medicine (the applications of DNA knowledge to medical practice) has moved into the genomics era with the promise that personalized medical care will now be greatly enhanced, including the options for more effective prevention and the development of new therapies targeted to molecular defects. At the same time, the traditional health professional-patient interaction is being challenged by the growth of Internet-based direct-to-consumer DNA testing and counseling. The increasing internationalization of genomic research has led to the development of more effective approaches to studying complex multifactorial genetic disorders, while at the same time highlighting new challenges in ethical, legal and social issues. In this complex environment, students and a wide range of health professionals need to keep abreast of new developments (often driven by the public, media or the Internet) while not necessarily having the opportunity or time to understand the basics.

Personalized healthcare refers specifically to the use of genetics and genomics. An example of that medicine includes the uses of specific tumor markers to guide therapy for breast cancer. We view personalized healthcare as a broader platform that includes genetics and genomics but also includes any other biologic information that helps predict risk for disease or how a patient will respond to treatments. Most genetic disorders are quite rare and affect one person in every several thousands or millions. Molecular and Cellular Therapies is the cellular modifications at the molecular level. Take the chemotherapy in oncology for example, it aims to kill the cell by delivering toxic agents to the cell, while Molecular therapies could aim to terminate the cellular division without necessarily killing the cell, such as aiming to reach senescence whose therapeutic procedure, levels of toxic agents, and tools for delivering the toxicity could all be very different from simply killing the cell. Physicians specializing in internal medicine are called internists or physicians (without a modifier) in Commonwealth nations.

  • Pharmacoproteomics in Personalized Medicine
  • Plant Genomics
  • Preventive Medicines
  • Regulatory Of Personalized Medicine
  • Treatment Of Genetic Disorders
  • Treatment Of Immune Disorders
  • Treatment Of Infectious Diseases
  • Treatment Of Neurological & Psychiatric Disorders
  • Cell & Gene Therapy Insights

Related Conference of Molecular medicine and Personalized Healthcare

September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 21-22, 2017

International Conference on Glycobiology

Houston, Texas, USA
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 16-17, 2017

3rd Annual Congress on Bioscience

October 18-19, 2017

10th Annual Chemistry Congress

Osaka, Japan
October 25-26, 2017

Global Proteomics Conference

Dubai, UAE
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

glycobiology Biochem 2018

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

August 06-07, 2018

18th International Conference on Pediatrics Health

Madrid, Spain
July 16-18, 2018

World Congress on Green Chemistry and Green Engineering

Melbourne, Australia
August 22-23, 2018

5th Asia Pacific Gynecology and Obstetrics Congress

Tokyo, Japan
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 10-11, 2018

International Conference on Nutritional Biochemistry

Prague, Czech Republic

Molecular medicine and Personalized Healthcare Conference Speakers

Recommended Sessions

Related Journals

Are you interested in